I agree that this site is using cookies. You can find further informations here.
X
Chaves-Conde, Manuel
585  results:
english X
Search for persons X
?
1

Neoplastic appendiceal mucinous lesions: a narrative review..:

Ayala-de Miguel, Carlos ; Jiménez-Castro, Jerónimo ; Sánchez-Vegas, Adrián..
Clinical and Translational Oncology.  26 (2023)  6 - p. 1287-1299 , 2023
Link: https://doi.org/10.1007/..
 
?
2

Lenvatininb as Treatment for Naïve Patients with Aggressive..:

Garcia-Rodriguez, Sonia ; Pinillos, Guillermo Martinez ; Chaves-Conde, Manuel
Case Reports in Oncological Medicine.  2020 (2020)  - p. 1-4 , 2020
Link: https://doi.org/10.1155/..
 
?
3

A genetic view of laryngeal cancer heterogeneity:

de Miguel-Luken, María José ; Chaves-Conde, Manuel ; Carnero, Amancio
Cell Cycle.  15 (2016)  9 - p. 1202-1212 , 2016
Link: https://doi.org/10.1080/..
 
?
4

Phosphorylation of gH2AX as a novel prognostic biomarker fo..:

de Miguel-Luken, María José ; Chaves-Conde, Manuel ; Quintana, Begoña...
Oncotarget.  7 (2016)  22 - p. 31723-31737 , 2016
Link: https://doi.org/10.18632..
 
?
5

MAP17 (PDZKIP1) as a novel prognostic biomarker for larynge..:

de Miguel-Luken, María-José ; Chaves-Conde, Manuel ; de Miguel-Luken, Verónica...
Oncotarget.  6 (2015)  14 - p. 12625-12636 , 2015
Link: https://doi.org/10.18632..
 
?
6

A Colorectal Cancer Susceptibility New Variant at 4q26 in t..:

Real, Luis M. ; Ruiz, Agustín ; Gayán, Javier...
PLoS ONE.  9 (2014)  6 - p. e101178 , 2014
Link: https://doi.org/10.1371/..
 
?
7

Afatinib vs Placebo as Adjuvant Therapy After Chemoradiothe..:

Burtness, Barbara ; Haddad, Robert ; Dinis, José...
http://hdl.handle.net/10668/14105.  , 2019
Link: http://hdl.handle.net/10..
 
?
8

Phosphorylation of gH2AX as a novel prognostic biomarker fo..:

Jose de Miguel-Luken, Maria ; Chaves-Conde, Manuel ; Quintana, Begona...
http://hdl.handle.net/10668/19430.  , 2016
Link: http://hdl.handle.net/10..
 
?
9

Phosphorylation of gH2AX as a novel prognostic biomarker fo..:

de Miguel-Luken, María José ; Chaves-Conde, Manuel ; Quintana, Begoña...
http://hdl.handle.net/10668/10071.  , 2016
Link: http://hdl.handle.net/10..
 
?
10

Phosphorylation of gH2AX as a novel prognostic biomarker fo..:

Miguel-Luken, María José de ; Chaves-Conde, Manuel ; Quintana, Begoña...
Publisher's version.  , 2016
Link: http://hdl.handle.net/10..
 
?
11

A genetic view of laryngeal cancer heterogeneity:

de Miguel-Luken, María José ; Chaves-Conde, Manuel ; Carnero, Amancio
http://hdl.handle.net/10668/9892.  , 2016
Link: http://hdl.handle.net/10..
 
?
12

A genetic view of laryngeal cancer heterogeneity:

de Miguel-Luken, María José ; Chaves-Conde, Manuel ; Carnero, Amancio
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4894505/.  , 2016
Link: http://www.ncbi.nlm.nih...
 
?
13

A colorectal cancer susceptibility new variant at 4q26 in t..:

Real, Luis M ; Ruiz, Agustín ; Gayán, Javier...
Reproducció del document publicat a: https://doi.org/10.1371/journal.pone.0101178.  , 2014
Link: http://hdl.handle.net/24..
 
?
14

TTCC-2019-02: real-world evidence of first-line cetuximab p..:

Jordi Rubió-Casadevall ; Beatriz Cirauqui Cirauqui ; Javier Martinez Trufero...
https://www.frontiersin.org/articles/10.3389/fonc.2023.1226939/full.  , 2023
Link: https://doi.org/10.3389/..
 
?
15

Lenvatininb as Treatment for Naïve Patients with Aggressive..:

Sonia Garcia-Rodriguez ; Guillermo Martinez Pinillos ; Manuel Chaves-Conde
http://dx.doi.org/10.1155/2020/8679149.  , 2020
Link: https://doi.org/10.1155/..
 
1-15